Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.

Saved in:
Bibliographic Details
Title: Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Authors: Burkard, T.1, Kaiser, C. A.1, Brunner-La Rocca, H.2, Osswald, S.1, Pfisterer, M. E.1, Jeger, R. V.1
Source: Journal of Internal Medicine. Mar2012, Vol. 271 Issue 3, p257-263. 7p. 1 Diagram, 3 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:09546820
DOI:10.1111/j.1365-2796.2011.02423.x